SEK 274.3
(0.94%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 3.21 Billion SEK | 17.33% |
2022 | 2.73 Billion SEK | 24.85% |
2021 | 2.19 Billion SEK | 32.69% |
2020 | 1.65 Billion SEK | 9.27% |
2019 | 1.51 Billion SEK | 14.99% |
2018 | 1.31 Billion SEK | 6.51% |
2017 | 1.23 Billion SEK | 6.19% |
2016 | 1.16 Billion SEK | 5.41% |
2015 | 1.1 Billion SEK | 1.2% |
2014 | 1.08 Billion SEK | 8.11% |
2013 | 1 Billion SEK | -6.97% |
2012 | 1.08 Billion SEK | -4.45% |
2011 | 1.13 Billion SEK | 21.46% |
2010 | 933.72 Million SEK | -3.61% |
2009 | 968.67 Million SEK | -3.92% |
2008 | 1 Billion SEK | 2.25% |
2007 | 985.94 Million SEK | 15.39% |
2006 | 854.46 Million SEK | 3.5% |
2005 | 825.56 Million SEK | 17.98% |
2004 | 699.72 Million SEK | 9.84% |
2003 | 637.02 Million SEK | 34.81% |
2002 | 472.52 Million SEK | 30.72% |
2001 | 361.46 Million SEK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 3.17 Billion SEK | -1.21% |
2023 Q1 | 2.72 Billion SEK | -0.31% |
2023 Q4 | 3.21 Billion SEK | 13.88% |
2023 Q3 | 2.81 Billion SEK | 4.64% |
2023 Q2 | 2.69 Billion SEK | -1.23% |
2023 FY | 3.21 Billion SEK | 17.33% |
2022 Q3 | 2.26 Billion SEK | 11.23% |
2022 FY | 2.73 Billion SEK | 24.85% |
2022 Q2 | 2.03 Billion SEK | -2.39% |
2022 Q1 | 2.08 Billion SEK | -4.69% |
2022 Q4 | 2.73 Billion SEK | 20.66% |
2021 Q1 | 1.63 Billion SEK | -1.06% |
2021 Q2 | 1.69 Billion SEK | 3.43% |
2021 Q3 | 1.82 Billion SEK | 8.14% |
2021 Q4 | 2.19 Billion SEK | 19.89% |
2021 FY | 2.19 Billion SEK | 32.69% |
2020 FY | 1.65 Billion SEK | 9.27% |
2020 Q1 | 1.38 Billion SEK | -8.14% |
2020 Q3 | 1.47 Billion SEK | 13.94% |
2020 Q2 | 1.29 Billion SEK | -6.96% |
2020 Q4 | 1.65 Billion SEK | 12.21% |
2019 Q3 | 1.41 Billion SEK | 13.9% |
2019 Q2 | 1.24 Billion SEK | -5.81% |
2019 Q1 | 1.31 Billion SEK | 0.25% |
2019 FY | 1.51 Billion SEK | 14.99% |
2019 Q4 | 1.51 Billion SEK | 6.91% |
2018 Q1 | 1.19 Billion SEK | -2.8% |
2018 Q3 | 1.15 Billion SEK | 4.12% |
2018 Q4 | 1.31 Billion SEK | 13.45% |
2018 FY | 1.31 Billion SEK | 6.51% |
2018 Q2 | 1.11 Billion SEK | -7.23% |
2017 Q1 | 1.14 Billion SEK | -1.56% |
2017 FY | 1.23 Billion SEK | 6.19% |
2017 Q3 | 1.07 Billion SEK | 3.99% |
2017 Q2 | 1.03 Billion SEK | -9.41% |
2017 Q4 | 1.23 Billion SEK | 14.5% |
2016 Q1 | 1.09 Billion SEK | -0.41% |
2016 FY | 1.16 Billion SEK | 5.41% |
2016 Q3 | 1.06 Billion SEK | 9.37% |
2016 Q2 | 974.58 Million SEK | -11.27% |
2016 Q4 | 1.16 Billion SEK | 9.06% |
2015 Q3 | 1.04 Billion SEK | 10.32% |
2015 Q2 | 942.99 Million SEK | -13.53% |
2015 Q1 | 1.09 Billion SEK | 0.07% |
2015 Q4 | 1.1 Billion SEK | 6.01% |
2015 FY | 1.1 Billion SEK | 1.2% |
2014 Q4 | 1.08 Billion SEK | 8.72% |
2014 Q3 | 1 Billion SEK | 7.68% |
2014 Q2 | 930.94 Million SEK | -7.91% |
2014 Q1 | 1.01 Billion SEK | 0.28% |
2014 FY | 1.08 Billion SEK | 8.11% |
2013 Q4 | 1 Billion SEK | 2.93% |
2013 Q1 | 1.03 Billion SEK | -4.31% |
2013 Q2 | 898.86 Million SEK | -13.31% |
2013 Q3 | 979.3 Million SEK | 8.95% |
2013 FY | 1 Billion SEK | -6.97% |
2012 Q1 | 1.12 Billion SEK | -1.1% |
2012 Q3 | 996.27 Million SEK | 2.51% |
2012 Q4 | 1.08 Billion SEK | 8.76% |
2012 FY | 1.08 Billion SEK | -4.45% |
2012 Q2 | 971.86 Million SEK | -13.35% |
2011 Q2 | 1.22 Billion SEK | 37.04% |
2011 Q1 | 894.45 Million SEK | -4.21% |
2011 FY | 1.13 Billion SEK | 21.46% |
2011 Q4 | 1.13 Billion SEK | 3.28% |
2011 Q3 | 1.09 Billion SEK | -10.42% |
2010 Q4 | 933.72 Million SEK | 2.06% |
2010 FY | 933.72 Million SEK | -3.61% |
2010 Q3 | 914.92 Million SEK | -2.25% |
2010 Q1 | 933.83 Million SEK | -3.6% |
2010 Q2 | 936.01 Million SEK | 0.23% |
2009 Q4 | 968.67 Million SEK | 0.0% |
2009 FY | 968.67 Million SEK | -3.92% |
2008 FY | 1 Billion SEK | 2.25% |
2007 FY | 985.94 Million SEK | 15.39% |
2006 FY | 854.46 Million SEK | 3.5% |
2005 FY | 825.56 Million SEK | 17.98% |
2004 FY | 699.72 Million SEK | 9.84% |
2003 FY | 637.02 Million SEK | 34.81% |
2002 FY | 472.52 Million SEK | 30.72% |
2001 FY | 361.46 Million SEK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Acarix AB (publ) | 62.88 Million SEK | -5006.129% |
ADDvise Group AB (publ) | 3.28 Billion SEK | 2.326% |
ADDvise Group AB (publ) | 3.28 Billion SEK | 2.326% |
Arcoma AB | 81.96 Million SEK | -3817.594% |
Bactiguard Holding AB (publ) | 682.87 Million SEK | -370.207% |
BICO Group AB (publ) | 10.19 Billion SEK | 68.51% |
Boule Diagnostics AB (publ) | 755.1 Million SEK | -325.233% |
CellaVision AB (publ) | 928.71 Million SEK | -245.741% |
Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -5462.474% |
Chordate Medical Holding AB (publ) | 21.95 Million SEK | -14524.769% |
C-Rad AB (publ) | 404 Million SEK | -694.787% |
Duearity AB (publ) | 15.14 Million SEK | -21102.707% |
Dignitana AB (publ) | 44.83 Million SEK | -7062.316% |
Episurf Medical AB (publ) | 104.3 Million SEK | -2978.56% |
Getinge AB (publ) | 55.09 Billion SEK | 94.172% |
Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -3028.402% |
Iconovo AB (publ) | 128.07 Million SEK | -2406.981% |
Integrum AB (publ) | 164.85 Million SEK | -1847.686% |
Luxbright AB (publ) | 40.68 Million SEK | -7791.869% |
Mentice AB (publ) | 322.52 Million SEK | -895.559% |
OssDsign AB (publ) | 356.38 Million SEK | -800.964% |
Paxman AB (publ) | 167.12 Million SEK | -1821.279% |
Promimic AB (publ) | 92.87 Million SEK | -3357.268% |
Qlife Holding AB (publ) | 39.04 Million SEK | -8123.475% |
SciBase Holding AB (publ) | 64.33 Million SEK | -4891.044% |
ScandiDos AB (publ) | 81.47 Million SEK | -3841.107% |
Sedana Medical AB (publ) | 1.01 Billion SEK | -216.643% |
Senzime AB (publ) | 433.54 Million SEK | -640.629% |
SpectraCure AB (publ) | 144.83 Million SEK | -2116.978% |
Stille AB | 804.89 Million SEK | -298.927% |
Vitrolife AB (publ) | 16.39 Billion SEK | 80.41% |
Xvivo Perfusion AB (publ) | 2.19 Billion SEK | -46.243% |